Kris S. Chang

1.3k total citations
6 papers, 999 citations indexed

About

Kris S. Chang is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Kris S. Chang has authored 6 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Kris S. Chang's work include Hedgehog Signaling Pathway Studies (5 papers), Genetic and rare skin diseases. (4 papers) and Tumors and Oncological Cases (2 papers). Kris S. Chang is often cited by papers focused on Hedgehog Signaling Pathway Studies (5 papers), Genetic and rare skin diseases. (4 papers) and Tumors and Oncological Cases (2 papers). Kris S. Chang collaborates with scholars based in United States. Kris S. Chang's co-authors include Ervin H. Epstein, Jean Y. Tang, Robert L. Yauch, Michelle Aszterbaum, Julian Mackay‐Wiggan, Anita M. Chanana, David R. Bickers, Joselyn Lindgren, Jackleen Marji and Juyong Brian Kim and has published in prestigious journals such as New England Journal of Medicine, Cancer Cell and Cancer Research.

In The Last Decade

Kris S. Chang

6 papers receiving 977 citations

Peers

Countries citing papers authored by Kris S. Chang

Since Specialization

Citations

This map shows the geographic impact of Kris S. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kris S. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kris S. Chang more than expected).

Fields of papers citing papers by Kris S. Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kris S. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kris S. Chang. The network helps show where Kris S. Chang may publish in the future.

Co-authorship network of co-authors of Kris S. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Kris S. Chang. A scholar is included among the top collaborators of Kris S. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kris S. Chang. Kris S. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome 2012 ·New England Journal of Medicine ·Jean Y. Tang, Julian Mackay‐Wiggan, Michelle Aszterbaum, Robert L. Yauch, Joselyn Lindgren, Kris S. Chang, (unknown), Anita M. Chanana, Jackleen Marji, David R. Bickers, Ervin H. Epstein	383
2	Nanoelectroablation therapy for murine basal cell carcinoma 2012 ·Biochemical and Biophysical Research Communications ·Richard Nuccitelli, Kevin Tran, Brian Athos, Mark Kreis, Pamela Nuccitelli, Kris S. Chang, Ervin H. Epstein, Jean Y. Tang	38
3	Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened 2011 ·Clinical Cancer Research ·Tracy Tang, Jean Y. Tang, Dongwei Li, Mike Reich, Christopher A. Callahan, Ling Fu, Robert L. Yauch, Frank Wang, Karen Kotkow, Kris S. Chang, (unknown), Angela Ruohao Wu, Lee L. Rubin, James C. Marsters, Ervin H. Epstein, Ivor Caro, Frédéric J. de Sauvage	53
4	Vitamin D3 Inhibits Hedgehog Signaling and Proliferation in Murine Basal Cell Carcinomas 2011 ·Cancer Prevention Research ·Jean Y. Tang, (unknown), Yuko Oda, Kris S. Chang, (unknown), Angela Ruohao Wu, Po-Lin So, Jennifer Hebert, Daniel D. Bikle, Ervin H. Epstein	95
5	Abstract LB-1: An investigator-initiated, phase II randomized, double-blind, placebo-controlled trial of GDC-0449 for prevention of BCCs in basal cell nevus syndrome (BCNS) patients.gg 2011 ·Cancer Research ·Jean Y. Tang, Julian Mackay‐Wiggan, Michelle Aszterbaum, Joselyn Lindgren, Kris S. Chang, (unknown), Angela Campbell, Anita M. Chanana, Jackleen Marji, (unknown), Robert L. Yauch, David R. Bickers, Ervin H. Epstein	9
6	Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth 2010 ·Cancer Cell ·James Kim, Jean Y. Tang, Ruoyu Gong, Juyong Brian Kim, John J. Lee, Karl V. Clemons, Curtis R. Chong, Kris S. Chang, Mark Fereshteh, Dale R. Gardner, Tannishtha Reya, Jun O. Liu, Ervin H. Epstein, David A. Stevens, Philip A. Beachy	421

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact